Literature DB >> 8943423

alpha1-Antitrypsin inhibits the lethal response to TNF in mice.

C Libert1, W Van Molle, P Brouckaert, W Fiers.   

Abstract

alpha1-Antitrypsin, an acute-phase reactant in many species, protects significantly against the lethality induced by TNF or endotoxin in mice. The protection is optimal with a single dose of at least 300 microg i.p. or 100 microg i.v. given 2 h before a lethal challenge, either with a low dose of TNF in the presence of galactosamine or a higher dose of murine TNF alone. Under optimal conditions, the drop in body temperature, the release of liver transaminases, and the increase in clotting time are also inhibited. alpha1-Antitrypsin does not protect against a lethal dose of platelet-activating factor. It is suggested that the protection is due to reduced release of platelet-activating factor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8943423

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

Review 1.  Lung disease associated with alpha1-antitrypsin deficiency.

Authors:  Rubin M Tuder; Sabina M Janciauskiene; Irina Petrache
Journal:  Proc Am Thorac Soc       Date:  2010-11

Review 2.  Immune-modulating effects of alpha-1 antitrypsin.

Authors:  Mario R Ehlers
Journal:  Biol Chem       Date:  2014-10       Impact factor: 3.915

3.  α-1-antitrypsin gene delivery reduces inflammation, increases T-regulatory cell population size and prevents islet allograft rejection.

Authors:  Galit Shahaf; Hadas Moser; Eyal Ozeri; Mark Mizrahi; Avishag Abecassis; Eli C Lewis
Journal:  Mol Med       Date:  2011-06-09       Impact factor: 6.354

4.  Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice.

Authors:  Eli C Lewis; Leland Shapiro; Owen J Bowers; Charles A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-10       Impact factor: 11.205

5.  Effects of alpha 1-antitrypsin on endotoxin-induced lung inflammation in vivo.

Authors:  Devipriya Subramaniyam; Chad Steele; Thomas Köhnlein; Tobias Welte; Olof Grip; Sadis Matalon; Sabina Janciauskiene
Journal:  Inflamm Res       Date:  2010-03-18       Impact factor: 4.575

6.  High-level constitutive expression of alpha 1-acid glycoprotein and lack of protection against tumor necrosis factor-induced lethal shock in transgenic mice.

Authors:  C Libert; T Hochepied; F G Berger; H Baumann; W Fiers; P Brouckaert
Journal:  Transgenic Res       Date:  1998-11       Impact factor: 2.788

Review 7.  Acute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threats.

Authors:  O Guttman; B M Baranovski; R Schuster; Z Kaner; G S Freixo-Lima; N Bahar; N Kalay; M I Mizrahi; I Brami; D E Ochayon; E C Lewis
Journal:  Clin Exp Immunol       Date:  2015-02       Impact factor: 4.330

8.  The major acute-phase protein, serum amyloid P component, in mice is not involved in endogenous resistance against tumor necrosis factor alpha-induced lethal hepatitis, shock, and skin necrosis.

Authors:  W Van Molle; T Hochepied; P Brouckaert; C Libert
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

9.  Platelet-activating factor: a previously unrecognized mediator of fever.

Authors:  Andrei I Ivanov; Shreya Patel; Vladimir A Kulchitsky; Andrej A Romanovsky
Journal:  J Physiol       Date:  2003-10-17       Impact factor: 5.182

10.  Regulation of pulmonary and systemic bacterial lipopolysaccharide responses in transgenic mice expressing human elafin.

Authors:  J-M Sallenave; G A Cunningham; R M James; G McLachlan; C Haslett
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.